Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy

Background/Aim: The primary objective of this study was to identify predictors for biochemical recurrence (BCR) within 2 years following robot-assisted radical prostatectomy (RARP). Identifying predictors will enable insights that enhance personalized patient management and facilitate the ongoing refinement of postoperative therapy strategies. Patients and Methods: This retrospective study included patients undergoing RARP from September 2014 to January 2021. Exclusion criteria were preoperative endocrine therapy, BCR beyond 2 years post-surgery, and incomplete postoperative data. Multivariate analyses were conducted to evaluate predictors of BCR, focusing on preoperative prostate- specific antigen (PSA) level, pathological tumor (pT) stage, Gleason score (GS), extraprostatic extension (EPE), and surgical margin status. Results: Among 374 patients, 40 experienced BCR within 2 years. Significant predictors of early BCR included initial PSA level >= 10 ng/ml, pT3 or greater, GS >= 8, EPE, and positive surgical margins (RM1). Multivariate analysis identified pT3 or higher, GS >= 8, and RM1 as independent risk factors for early BCR. Conclusion: Early BCR after RARP is significantly associated with advanced pathological stage, high GS, and positive surgical margins. These findings emphasize the need for tailored postoperative management strategies and highlight the importance of precision in surgical technique to improve patient outcomes.